Epigenetic modulator  LSD1, a theragnostic target for potentially malignant oral disorders and malignant lesions

Epigenomics,Volume 14, Issue 20, Page 1229-1232, October 2022.

Source: Future Medicine: Epigenomics - November 9, 2022 Category: Genetics & Stem Cells Authors: Vijayashree Priyadharsini Jayaseelan Paramasivam Arumugam Source Type: research